The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study

Challenges in breast and cervical cancer control in Japan

(2016) Catherine Sauvaget et al.   LANCET ONCOLOGY

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology

(2015) Theodoros Agorastos et al.   PLoS One

Tracking the global spread of vaccine sentiments: The global response to Japan's suspension of its HPV vaccine recommendation

(2014) Heidi J Larson et al.   Human Vaccines & Immunotherapeutics

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

(2012) Debbie Saslow et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study

(2012) J. Thomas Cox et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology

(2011) Mark H. Stoler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The ATHENA human papillomavirus study: design, methods, and baseline results

(2011) Thomas C. Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Trend analysis of cancer incidence in Japan using data from selected population-based cancer registries

(2011) Kota Katanoda et al.   CANCER SCIENCE

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

(2009) Mamiko Onuki et al.   CANCER SCIENCE